Search

Revicki, Dennis A, Mary Kaye Willian, Alan Menter, Kenneth B Gordon, Alexa B Kimball, Craig L Leonardi, Richard G Langley, Miriam Kimel, and Martin Okun. 2007. “Impact of Adalimumab Treatment on Patient-Reported Outcomes: Results from a Phase III Clinical Trial in Patients With Moderate to Severe Plaque Psoriasis.”. The Journal of Dermatological Treatment 18 (6): 341-50.

Marchetti, Albert, Steven R Feldman, Alexandra Boer Kimball, Richard Rox Anderson, Laurence H Miller, John Martin, and Peter An. 2005. “Treatments for Mild-to-Moderate Recalcitrant Plaque Psoriasis: Expected Clinical and Economic Outcomes for First-Line and Second-Line Care.”. Dermatology Online Journal 11 (1): 1.

Papp, Kim A, Bruce Strober, Matthias Augustin, Steve Calabro, Anil Londhe, Marc Chevrier, and PSOLAR investigators and Steering Committee. 2012. “PSOLAR: Design, Utility, and Preliminary Results of a Prospective, International, Disease-Based Registry of Patients With Psoriasis Who Are Receiving, or Are Candidates For, Conventional Systemic Treatments or Biologic Agents.”. Journal of Drugs in Dermatology : JDD 11 (10): 1210-7.

Bae, Yoon-Soo Cindy, Abby S Van Voorhees, Sylvia Hsu, Neil J Korman, Mark G Lebwohl, Melody Young, Bruce Bebo, Alexa Boer Kimball, and National Psoriasis Foundation. 2012. “Review of Treatment Options for Psoriasis in Pregnant or Lactating Women: From the Medical Board of the National Psoriasis Foundation.”. Journal of the American Academy of Dermatology 67 (3): 459-77.

Robinson, Amanda, Marisa Kardos, and Alexandra B Kimball. 2012. “Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why Do Both? A Systematic Analysis of Randomized Controlled Trials of Biologic Agents for Moderate to Severe Plaque Psoriasis.”. Journal of the American Academy of Dermatology 66 (3): 369-75.

Kimball, Alexa Boer, Andrew P Yu, James Signorovitch, Jipan Xie, Magda Tsaneva, Shiraz R Gupta, Yanjun Bao, and Parvez M Mulani. 2012. “The Effects of Adalimumab Treatment and Psoriasis Severity on Self-Reported Work Productivity and Activity Impairment for Patients With Moderate to Severe Psoriasis.”. Journal of the American Academy of Dermatology 66 (2): e67-76.

Abuabara, K, H Lee, and A B Kimball. 2011. “The Effect of Systemic Psoriasis Therapies on the Incidence of Myocardial Infarction: A Cohort Study.”. The British Journal of Dermatology 165 (5): 1066-73.

Ryan, Caitriona, Craig L Leonardi, James G Krueger, Alexa B Kimball, Bruce E Strober, Kenneth B Gordon, Richard G Langley, et al. 2011. “Association Between Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events: A Meta-Analysis of Randomized Controlled Trials.”. JAMA 306 (8): 864-71.

Lebwohl, Mark, Bruce Strober, Alan Menter, Kenneth Gordon, Jolanta Weglowska, Lluís Puig, Kim Papp, et al. 2015. “Phase 3 Studies Comparing Brodalumab With Ustekinumab in Psoriasis.”. The New England Journal of Medicine 373 (14): 1318-28.

Papp, K A, M A Menter, M Abe, B Elewski, S R Feldman, A B Gottlieb, R Langley, et al. 2015. “Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Chronic Plaque Psoriasis: Results from Two Randomized, Placebo-Controlled, Phase III Trials.”. The British Journal of Dermatology 173 (4): 949-61.